| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0008-6363(97)00142-9 |
| P698 | PubMed publication ID | 9415275 |
| P2093 | author name string | E Hodge | |
| M Shou | |||
| E F Unger | |||
| D F Lazarous | |||
| J A Stiber | |||
| V Thirumurti | |||
| D M Dadhania | |||
| P433 | issue | 1 | |
| P921 | main subject | pharmacodynamics | Q725307 |
| P304 | page(s) | 78-85 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution | |
| P478 | volume | 36 |
| Q64056424 | Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure |
| Q35094462 | Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. |
| Q35589939 | Biopolymeric delivery matrices for angiogenic growth factors. |
| Q34149528 | Cell-responsive hydrogel for encapsulation of vascular cells |
| Q37177994 | Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization |
| Q36837265 | Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model |
| Q37766126 | Delivery of gene and cellular therapies for heart disease |
| Q38524618 | Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial. |
| Q44773869 | Distribution of Intramyocardially injected extracellular MR contrast medium: effects of concentration and volume |
| Q40568802 | Effects of basic fibroblastic growth factor on the growth of human medulloblastoma xenografts |
| Q73392873 | Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia |
| Q50513323 | Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. |
| Q34994526 | Engineering and visualization of bacteria for targeting infarcted myocardium |
| Q30439954 | Engineering vascularized tissues using natural and synthetic small molecules |
| Q33890932 | Enhanced collateral growth by double transplantation of gene-nucleofected fibroblasts in ischemic hindlimb of rats. |
| Q50515836 | Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine hearts. |
| Q26863362 | Gene delivery technologies for cardiac applications |
| Q35937557 | Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia |
| Q93173865 | Harnessing stem cells and biomaterials to promote neural repair |
| Q34190135 | Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease |
| Q73453266 | Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs |
| Q74217847 | Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization |
| Q42376356 | Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium |
| Q73665614 | Intrapericardial therapeutics and diagnostics |
| Q34463346 | Intrapericardial therapy and diagnosis |
| Q36746521 | MR imaging in assessing cardiovascular interventions and myocardial injury |
| Q36108746 | MRI in guiding and assessing intramyocardial therapy. |
| Q48797990 | Nanodiamond-based injectable hydrogel for sustained growth factor release: Preparation, characterization and in vitro analysis |
| Q48723538 | Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention. |
| Q42556394 | Optimal amount of basic fibroblast growth factor in gelatin sponges incorporating β-tricalcium phosphate with chondrocytes |
| Q77853754 | Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery |
| Q77808667 | Safety of subxyphoid pericardial access using a blunt-tip needle |
| Q59261110 | Selective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia |
| Q34312563 | Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2) |
| Q36933339 | The FGF family: biology, pathophysiology and therapy |
| Q38103601 | The future of collateral artery research |
| Q33705144 | The road ahead: working towards effective clinical translation of myocardial gene therapies |
| Q58914975 | Therapeutic angiogenesis using basic fibroblast growth factor in combination with a collagen matrix in chronic hindlimb ischemia |
| Q74372344 | Therapeutic angiogenesis: a step forward in intermittent claudication |
| Q27023731 | Therapeutic angiogenesis: controlled delivery of angiogenic factors |
| Q35949638 | Therapeutic myocardial angiogenesis with vascular endothelial growth factors |
| Q92677843 | Tissue Engineering of the Microvasculature |
| Q90295290 | Tracheal cartilage growth promotion by intra-tracheal administration of basic FGF |
| Q33713721 | VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial |
| Q41952122 | Vascular regeneration by local growth factor release is self-limited by microvascular clearance |
Search more.